The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRDL.L Regulatory News (RDL)

  • There is currently no data for RDL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Corporate Update

15 Jun 2017 07:00

RNS Number : 1280I
Ranger Direct Lending Fund PLC
15 June 2017
 

 

15 June 2017

RANGER DIRECT LENDING FUND PLC

Corporate Update -Borrowing Policy, Investment Restrictions and Princeton

 

Ranger Direct Lending Fund plc (the "Company") wishes to provide shareholders with an update regarding the Company's investment approach to its portfolio, as well as on its investment in Princeton Alternative Income Fund Ltd ("Princeton").

In addition to the updates set out below, the Company has been informed by Ranger Alternative Management II LLP (the "Investment Manager") that it intends to utilise part of its management fee to acquire ordinary shares in the market in order to demonstrate its confidence in the Company's investment strategy. Further announcements, as required by applicable regulation in respect of such purchases, will be made in due course.

Borrowing Policy

 

As disclosed in the prospectus published by the Company on 21 November 2016 (the "Prospectus"), the Company is permitted to employ borrowings (through bank or other facilities and whether directly or indirectly through an investment fund in which it invests or through a subsidiary SPV), up to 50 per cent. of Net Asset Value, in aggregate (calculated at the time of draw down under any facility that the Company has entered into).

 

To date, the Company's wholly owned subsidiary, Ranger Direct Lending ZDP plc, has issued 53 million zero dividend preference shares raising gross proceeds of £53,805,000, the entirety of which have been loaned to the Company. The Company has not incurred any other borrowings.

 

Accordingly, the Company's current borrowings as a percentage of Net Asset Value based on the last published Net Asset Value of the Company are 29.30 per cent.

 

The Board has today instructed the Investment Manager not to exercise its borrowing powers as set out in the borrowing policy to incur any senior borrowings through the provision of credit facilities by financial institutions over the next twelve months, so as not to incur any debt that has preference over the existing zero dividend preference shares.

 

Investment Restrictions

 

The Company's current investment restrictions prevent the Company from, inter alia, investing:

 

· more than 35 per cent. of Gross Assets in Debt Instruments that are not secured (directly or indirectly) by assets and/or personal guarantees; or

 

· more than 25 per cent. of Gross Assets in Debt Instruments originated through or issued by any single Direct Lending Platform,

 

with such restrictions assessed at the time of investment.

 

The Board has resolved, having regard to the Company's current exposure to Princeton and to the performance of the portfolio as a whole, that the Investment Manager should seek to realign the Company's portfolio with the aim of increasing the diversification of the portfolio as and when existing Debt Instruments mature.

 

Accordingly, the Company intends to target the following investment thresholds within the investment restrictions set out in the Company's investment policy, in each case at the time of investment by the Company:

 

· as existing investments mature over the next two years, the Investment Manager will seek to reduce the percentage of the portfolio that is attributable to Debt Instruments that are not secured (directly or indirectly) by assets and/or personal guarantees (i.e. Debt Instruments that are exposed to unsecured consumer lending) with a target that such investments do not represent more than 15 per cent. of Gross Assets by the end of that period; and

 

· as existing investments mature over the next 18 months the Investment Manager will target a portfolio allocation whereby aggregate investments in Debt Instruments originated through or issued by any single Direct Lending Platform do not exceed 15 per cent. of Gross Assets, but in any event, the Investment Manager will seek to ensure that such investments in Debt Instruments originated through or issued by any single Direct Lending Platform shall not exceed 20 per cent. of Gross Assets.

 

The Board believes that by phasing in such restrictions over a two year period as existing Debt Instruments mature, the Company's portfolio will realign organically and remain consistent with the Company's investment objective and policy.

 

Princeton

Finally, with respect to the Company's outstanding redemption request with Princeton, the Company has not yet reached agreement with Princeton with respect to a redemption plan. The Company will continue to seek resolution and reserves all rights and courses of action available to it in connection with its investment in Princeton.

 

Terms used but not defined in this announcement shall have the meaning ascribed to them in the Prospectus.

 

For further information, please contact:

Capita Company Secretarial Services Limited

+44 (0)20 7954 9531

Secretary

Ranger Capital Group

Via Redleaf PR

Bill Kassul

Scott Canon

Liberum Capital Limited

+44 (0)20 3100 2000

Media Enquiries

ranger@redleafpr.com

Redleaf Communications

+44 (0)20 7382 4730

Rebecca Sanders-Hewett

David Ison

Sam Modlin

 

IMPORTANT INFORMATION

This announcement may include "forward-looking statements". All statements other than statements of historical facts included in this announcement, including, without limitation, those regarding the Company's financial position, business strategy, plans and objectives of management for future operations (including development plans and objectives relating to the Company's products and services) are forward-looking statements.

Forward-looking statements are subject to risks and uncertainties and accordingly the Company's actual future financial results and operational performance may differ materially from the results and performance expressed in, or implied by, the statements. These factors include but are not limited to those described in the formal prospectus. These forward-looking statements speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to update or revise any forward-looking statements contained herein to reflect actual results or any change in the assumptions, conditions or circumstances on which any such statements are based unless required to do so by the Financial Services and Markets Act 2000, the Listing Rules or Prospectus Rules of the Financial Conduct Authority or other applicable laws, regulations or rules.

END OF ANNOUNCEMENT

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDEAAKLFFEXEAF
Date   Source Headline
25th Jan 202111:50 amRNSPortfolio Update
12th Jan 20211:12 pmRNSResult of General Meeting
23rd Dec 20207:00 amRNSPortfolio Update
21st Dec 20204:59 pmRNSPublication of Delisting Circular and Notice of GM
21st Dec 20204:59 pmRNSHolding(s) in Company
10th Dec 20205:20 pmRNSDividend Declaration
27th Nov 20205:37 pmRNSHolding(s) in Company
25th Nov 20207:00 amRNSChange of AIFM and intention to delist
24th Nov 202010:31 amRNSPortfolio Update
26th Oct 20209:56 amRNSPortfolio Update
23rd Oct 20204:41 pmRNSSecond Price Monitoring Extn
23rd Oct 20204:36 pmRNSPrice Monitoring Extension
12th Oct 20207:00 amRNSPortfolio Update
22nd Sep 20207:00 amRNSHalf-year Report
16th Sep 20204:34 pmRNSDirector Declaration
9th Sep 202012:31 pmRNSPortfolio Update
20th Aug 202012:07 pmRNSSecond Price Monitoring Extn
20th Aug 202012:02 pmRNSPrice Monitoring Extension
22nd Jul 20209:43 amRNSPortfolio Update
9th Jul 202011:16 amRNSDirector Declaration
30th Jun 20203:37 pmRNSResult of AGM
24th Jun 20202:48 pmRNSPortfolio Update
8th Jun 20204:41 pmRNSSecond Price Monitoring Extn
8th Jun 20204:35 pmRNSPrice Monitoring Extension
4th Jun 20207:00 amRNSAnnual Financial Report
28th May 20206:00 pmRNSRevised Publication Date For The Annual Report
15th May 20204:40 pmRNSSecond Price Monitoring Extn
15th May 20204:35 pmRNSPrice Monitoring Extension
4th May 202011:21 amRNSPortfolio Update
30th Apr 20202:41 pmRNSPublication Date for Annual Report
27th Apr 20209:58 amRNSDisclosure of Rights Attaching to Equity Shares
7th Apr 20207:00 amRNSDividend Declaration
2nd Apr 202010:54 amRNSResignation of Director
30th Mar 20202:02 pmRNSPortfolio Update
16th Mar 20207:00 amRNSPrinceton Update
11th Mar 20207:00 amRNSPortfolio Update
20th Feb 20205:06 pmRNSPrinceton Update
3rd Feb 20207:00 amRNSPortfolio Update
17th Jan 20209:44 amRNSHolding(s) in Company
10th Jan 20204:41 pmRNSPrinceton Update
9th Jan 202012:11 pmRNSDividend Declaration
31st Dec 201911:18 amRNSUpdate - Standstill Agreement
24th Dec 201910:11 amRNSHolding(s) in Company
23rd Dec 20194:49 pmRNSPortfolio Update
10th Dec 201910:12 amRNSDirector Declaration
26th Nov 201911:29 amRNSPortfolio Update
26th Nov 20197:00 amRNSDividend Declaration
6th Nov 201910:07 amRNSPortfolio Update
28th Oct 20194:50 pmRNSDirector Declaration
24th Oct 201911:21 amRNSPortfolio Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.